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Abstract
The era of genomics has brought tremendous advancement especially in the fields of medicine and life sciences.  Despite the
overwhelming growth of information generated from genomics research, a huge gap specifically in relation to genome expression
persists, and became increasingly noticeable.  This has sparked interest in studies of proteins expression and eventually added
limelight to the field of proteomics.  Aside from the need to fill the gap, the emergence of proteomics is also deemed to have
occurred due to the advancement in capabilities of research techniques, particularly in the separation and identification of proteins.
Proteomics has since progressed and is slowly extending into other research as well as applied subspecialties.  This brief overview




Proteomics is broadly defined as the systematic analysis
of the protein expression of a proteome.  The term
‘proteome’ was introduced to describe an entire protein
complement expressed by a genome, or by a particular
cell or specific tissue type [1,2].  In many cases, the
proteome is a virtual reality that arises from accumulation
of data obtained from separate analyses of subproteomes,
which were done at different times and under different
experimental settings and conditions.  It is therefore an
annotation of all normal/wild type proteins that may be
expressed by a genome with complete disregard of the
differences of time, conditions or regulatory parameters.
Thus, all studies annotating or analyzing the genomic
expression in the form of proteins being expressed within
a defined proteome or subproteome are termed proteomics.
Why is Proteomics Necessary?
Aside from water, protein is the main constituent of
the human body.  The body’s function is also orchestrated
by proteins in the form of its structures, biocatalysts,
modulator and transporter molecules, metabolites as well
as an energy source at crucial times of requirement.
Proteins not only form the human body but operate it.  It
is also the main site of action of most drugs that are used
to manipulate and assert necessary changes to the
physiological conditions of the human body as and when
required.  Perhaps the greatest expectation from
proteomics comes from research carried out to identify
new protein targets in transformed cell lines and diseased
tissues for the actions of specific drugs.  Added knowledge
on proteins interaction may also drive new initiatives to
design better drugs.  In order to gain further insight into
many diseased conditions, in-depth knowledge and
understanding of protein expression and interaction, i.e.,
the processes that uphold the normal physiological
functions of the human body, is increasingly in demand.
Although the synthesis of proteins is directed by the
genome, the expression of proteins within a cell cannot
be directly predicted from genomic information.  It is not
always a direct complement of the genome.  For example,
the proopiomelanocortin gene when expressed in the
corticotrophic cells of the anterior pituitary generates
adrenocorticotropic hormone and β-lipotropin, but
expression of the same gene in the cells of the
intermediary pituitary gland produces a different set of
hormones comprising α-melanocyte-stimulating hormone,
corticotrophin-like intermediary peptide, γ-lipotropin and
β-endorphin [3].   This phenomenon which is attributed
to differential peptide processing, together with other
mechanisms like alternative splicing, mRNA editing,
polyadenylation and post-translational modifications, by
and large, results in different forms of protein products
that all arise from the same genome (Fig. 1).  Further
additions to this complexity are the facts that different
cells or tissues express different genes and many of these
genes are not constitutively expressed but rely on the
presence of specific modulators.  All proteins are also
continuously degraded, sorted and may be modified upon
interaction with other proteins.  Thus, the dynamics of
protein expression and interaction within a defined
proteome at various stages and conditions, more often
than not, could only be unraveled at its level and not
possibly deduced from mere genomic information.  This
has become even clearer when analysis of mRNA
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expression using methods like serial analysis of gene
expression and DNA microarray technology have now
shown poor correlation between mRNA and protein
expression levels [4-6].
At tandem with the need to perform its studies, the era
of proteomics has also evolved from the advancement of
techniques used in the identification and separation of
proteins.  A tremendous leap has generally taken place as
proteins can now be identified using mass spectrometry
and the separation of proteins by two-dimensional gel
electrophoresis (2-DE) is modified and improved.  An
attribute to the genomic work, compilation of cDNA
sequences of proteins are directly translated into putative
amino acid sequences.  By identifying specific positions
of trypsin action, amino acid sequences of polypeptides
within the cleavage points of the enzyme are identified.
The masses of the putative tryptic peptides of proteins
are deciphered from databases, which are then used as
references, in the form of peptide mass fingerprints (PMF),
for identification of proteins.  In the process of identifying
a protein, masses of its tryptic peptides, obtained by
mass spectrometry analysis, are generally used to search
for matching PMFs in the database.  Identification is
generally achieved when considerable matches are made.
As for the separation of proteins, although the use of
2-DE has been reported as early as 1975 by O’Farrell [7]
and Scheele [8], its popularity was only seen
approximately twenty years later when the technique was
proven to be reproducible and more convenient [9].  This
was made possible mainly when the problem of gel
gradient drift [10] was remedied with the use of
immobilised pH gradient in replacement of carrier
ampholytes [11].
Applications of Proteomics
At present, proteomics may be categorized into three
different types, i.e., expression proteomics, structural
proteomics and functional proteomics, depending on its
application.   Expression proteomics, which is also called
classical proteomics, is the quantitative study of protein
expression between samples that differ by some variables
using a combination of separation and identification
techniques like 2-DE and mass spectrometry.  In this
case, variables would include comparison between
different cells or tissues, stages of a disease, the states of
being induced or inhibited, normal or diseased, treated or
non-treated and many others.  The data obtained from
such comparison studies will certainly enhance
understanding in the specific areas of medicine or life
sciences.  Differences in the expression of the proteins
that are detected in the analyses of the proteome or
subproteome may also form a basis for further
investigations to seek improvements in techniques and
methodologies that are currently being applied in diagnosis
and treatment of patients.
Our studies comparing the serum 2-DE protein profiles
of patients with breast and nasopharyngeal cancers with
that of matching normal healthy controls are examples of
expression proteomics.  By comparing the serum protein
profiles of normal individuals with that of newly detected
and untreated patients with breast cancer, we were able
to demonstrate significant differences in the expression
of several acute-phase proteins [12].  Identities of the
serum proteins were verified by mass spectrometry.  The
aberrant expression of some of the proteins was validated
by ELISA as well as by immunohistochemical staining
of the respective lesions of the breast.  Unlike that of
patients with breast cancer, the sera of patients with
nasopharyngeal carcinoma (NPC) demonstrated 2-DE
protein profiles similar to that of the controls, with
exception of the ceruloplasmin spots, which appeared
up-regulated [13].  The enhanced ceruloplasmin
expression, which was also validated by ELISA studies,
was normalized when the NPC patients were treated.
Immunohistochemical analysis of nasopharyngeal lesions
of NPC patients demonstrated positive staining for
ceruloplasmin only at the malignant areas.  These
expression proteomics studies may form a basis for further
research to investigate whether the differentially expressed
proteins may be used as additional biomarkers to aid
diagnoses of both the cancers or to monitor the progress


















Figure 1: Genomic expression.  Due to multiple processing and regulatory mechanisms at different stages of the expression
of a gene, multiple protein products may be generated.
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Structural proteomics are studies whose goal is to
map out all free proteins or protein complexes that are
present in a specific cellular organelle.  This involves
attempts to identify all proteins within an organelle or a
multiprotein complex, determine where they are located,
and characterize all protein-protein interactions.
Establishment of subproteomes by isolating specific
subcellular organelles or protein complexes by purification
can greatly simplify analysis of structural proteomics
[14].  Identifying the proteins and activities localized to
specific cellular compartments provides insight on the
structural organization of the cell.  Analysis of the nuclear
pore complex of yeast is a good example of this subtype
of proteomics [15].  The data obtained has helped piece
together the overall architecture of yeast cells and explain
how expression of certain proteins contributes to the
unique characteristics of a cell.
Functional proteomics is a broad term generally used
to define many specific, directed proteomic approaches,
usually under non-denaturing conditions and smaller
subset of proteins.  In some studies, specific subproteomes
are isolated by affinity chromatography and analyzed for
their protein expression.  This could include the isolation
of protein complexes or the use of protein ligands to
isolate specific types of proteins or glycoproteins.  This
approach, which seems to have attracted more interest in
recent years, allows a selected group of proteins to be
analyzed and characterized in their native forms, and can
provide important information about disease mechanisms,
protein signaling or protein-drug interactions.
More recently, the use of protein microarrays as an
approach in functional proteomics has been explored [16].
Microarrays, generated by spotting biomolecules on a
solid surface at high spatial density, offer miniaturized,
robust platforms for high-throughput study of proteins.
Two different forms of protein microarrays have been
described.   The abundance-based microarrays measures
the abundance of specific biomolecules using analyte-
specific reagents such as antibodies, while the function-
based   microarrays examines protein functions by printing
a collection of target proteins on the array surface and
assessing their interactions and biochemical activities.
A good example of functional proteomics is the use of
protein microarrays in the form of chip-based antibodies
to screen labeled sera from patients with prostate cancer
for potential biomarkers [17].   A capture microarray
containing 184 antibodies targeting serum proteins,
proteins previously detected in sera of cancer patients
and intracellular proteins were used.    From this, five
proteins were demonstrated to be able to discriminate
prostate cancer serum from control.  Four of these serum
proteins were those that had been previously associated
with prostate cancer.
Proteomics Technology
The technology of proteomics is generally divisible
into three different stages involving separation,
identification and quantification of proteins.
Separation of Proteins
Proteomics analysis by mass spectrometry may be
carried out on proteins that are separated by one-
dimensional gel electrophoresis (1-DE).  The technique
is simple to perform, reproducible and can generally
separate proteins that differ by a few kDa.  Nevertheless,
the resolving power of 1-DE is rather limited and thus,
the technique is usually carried out on protein mixtures
after some stages of purification.  Separation of proteins
by 1-DE occurs on the basis of differences of molecular
mass.
For more complex mixtures of proteins such as a
crude cell lysate, high-resolution 2-DE is a better choice.
2-DE separates proteins on the basis of their net charge
in the first dimension and molecular mass in the second
dimension.  Despite being labor-intensive and time
consuming, the technique has become a popular choice
among researchers mainly due to its high resolving power
and reproducibility.  The technique has the ability to
resolve proteins that have undergone some form of post-
translational modification like phosphorylation [18] or
glycosylation [19].  The primary application of 2-DE is
in protein expression profiling.  The appearance and
disappearance of spots, usually detected by subjecting
the gels to silver staining, provide information on
differential protein expression while the intensity of the
spots provides quantitative information on protein
expression levels.
Although 2-DE is generally performed using a standard
protocol, modifications may be required depending on
samples to be analyzed.  Analysis by 2-DE generally
requires samples that are denatured, free of contaminants
(mainly salt) and at optimal loading concentration.
Denaturation of proteins is important so as to prevent
oxidation, aggregation and protein-protein interaction.
Under native conditions, proteins exists in different
conformations, may aggregate and interact with other
proteins and therefore cannot be analyzed by 2-DE.  Too
much salt in the sample disturbs isoelectric focusing and
leads to streaky patterns.  For comparative purposes, all
samples are to be kept and treated similarly as proteins
are continuously degraded and the rate of degradation of
protein varies at different conditions.
Despite many improvements, 2-DE is still limited in
its ability to resolve proteins that are large, hydrophobic
or those of extreme acidity or basicity [20].  A eukaryotic
cell lysate protein mixture may be too complexed to be
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completely resolved in a single 2-D gel [21].  Similarly,
it is also impossible to resolve all proteins of samples
with broad dynamic range, like plasma [22], in a single
2-DE gel.  Due to these limitations of 2-DE, several
alternative approaches have been used.  One approach is
to subject the entire protein sample mixture to trypsin
digestion and then purify the peptides before subjecting
them to analysis by mass spectrometry.  Several methods
have been used to purify the tryptic peptides including
liquid chromatography [23], capillary electrophoresis [24]
and a combination of ion-exchange chromatography and
reverse-phase chromatography [25].  However, these
methods require considerable effort, time and computing
power for data analysis.
Identification of Proteins
Progress in peptide analysis using mass spectrometry
has advanced very rapidly in recent years.  It is currently
the state of the art technique used in the identification of
proteins in proteomics analysis.  Prior to the use of mass
spectrometry, proteins were identified by Western blotting
and binding recognition using specific antibodies or on
the basis of their N-terminal sequences or Edman
sequencing.    While the earlier technique is dependent
on availability of antibodies, the latter technique is
restrictive and cannot be applied on proteins that are N-
terminally blocked.  Nevertheless, N-terminal sequencing
is still a viable alternative to mass spectrometry despite
its waning application.  In addition, an alternative protocol
for the sequencing of proteins, in the form of mixed
peptide sequencing, has been developed for protein
identification purposes [26].
Before analysis using a mass spectrometer, proteins
are initially subjected to peptide cleavage, usually with
trypsin (Fig. 2).  For proteins that are separated using gel
electrophoresis, trypsin digestion is usually performed
“in-gel” [27] as it is more efficient for sample recovery
than other methods like electroblotting or electroelution
[28].  Before being analyzed by mass spectrometry, the
peptide fragments recovered following in-gel digestion
need to be concentrated and purified to remove
contaminants such as salts, buffers and detergents, which
interfere with mass spectrometric analysis [29].  This is
usually performed using miniaturized chromatography
columns in the form of ZipTips, which purify proteins on
the basis of reverse-phase, ion exchange or affinity
chromatography principles.  Alternatively the samples
can also be subjected to high performance liquid
chromatography.
Figure 2: Mass spectrometric identification of proteins.  Analyses of tryptic peptide fragments by (a) MALDI-TOF and (b)
ESI-MS/MS generate data in the form of peptide mass fingerprints and sequence of amino acids, respectively.
Proteins may be identified by search of the peptide mass fingerprints or amino acid sequence in protein
databases (Table 1).
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Analysis of the concentrated peptide fragments by
mass spectrometry generates data in the forms of peptide
mass fingerprints or amino acid sequences.  In peptide
mass fingerprinting, a mass fingerprint or map of peptides
is derived from mass spectrometric analysis, e.g., by
using MALDI-TOF, of the trypsin-digested peptides (Fig.
2a).  By searching protein databases, the molecular masses
of this set of peptides are then measured and compared
against the theoretical molecular masses of known proteins
cleaved with the same protease in the database.
Identification is achieved when many of the molecular
masses match.  It is often not to find matches for all the
peptides as some may have been covalently modified
(e.g., glycopeptide) or resisted cleavage.
In the second approach, a tandem mass spectrometer
(MS/MS), which combines two mass analyzers or two
mass analysis steps, is indirectly used to determine the
amino acid sequence of a peptide.  In this approach, e.g.,
by using ESI-MS/MS, a peptide ion is further activated
using a gas-phase collision to break peptide bonds creating
a ladder of fragment ions (Fig. 2b).  Peptide fragmentation
which maintains the charge on the N-terminus is
designated b-ion, whereas fragmentation which maintains
the charge on the C-terminus is designated a y-ion.  The
fragment ions produced in the dissociation of peptides
reflect the sequence of amino acids and thus can be used
to search theoretical sequence databases.  Table 1
demonstrates some of the common databases available in
the internet that can be searched for peptide mass
fingerprints or sequencing.
The two main stages involved in mass spectrometry
are sample ionization and mass analysis.  Mass
spectrometry requires protein samples to be charged and
in dry form.  For this purpose, the highly concentrated,
purified and digested protein samples are initially
converted to desolvated ions either by matrix-assisted
laser desorbtion/ionization (MALDI) or electrospray
ionization (ESI).  In MALDI, the sample is incorporated
into matrix molecules and then subjected to irradiation
by a laser [30], while in ESI, the formation of desolvated
ions occur when a liquid sample evaporates as it flows
through a microcapillary tube that is induced with a
potential difference [31].  The biggest advantage of
MALDI is that sample application can be performed
using a robot so that the entire process including data
collection and analysis can be automated.  As such,
MALDI is more suitable for ionization of peptide samples
in high throughput studies.  Lately, the use of surface-
enhanced laser desorbtion/ionization (SELDI) in
proteomics analysis is also becoming popular [32].  Unlike
MALDI or ESI, SELDI is usually used to analyze complex
protein mixtures directly without the need of sample
preparation and purification steps.
Subsequent to their conversion to molecular ions,
peptides are then subjected to mass analysis using the
mass analyzers in mass spectrometers.  Analysis is usually
accomplished on the basis of the mass-to-charge (m/z)
ratio of a peptide ion in vacuum. There are currently
three main types of mass analyzers.  The time-of-flight
(TOF) instrument is among the simplest mass analyzers,
which measures the m/z ratio of an ion by measuring the
time required for it to traverse the length of a flight tube
[29].  The quadrupole analyzer consists of four parallel
metal rods through which the gas phase ions have to
achieve a stable trajectory.  The analyzer is operated by
the application of a voltage to create an electric field that
acts to transmit all ions or as mass filter to allow the
transmission of a certain m/z ratio [33].  If multiple
quadrupoles are combined, they can be used as a tandem
mass spectrometer to obtain information on the amino
acid sequence of a peptide.  Quadrupoles can also be
combined with the TOF mass analyzers to generate the
hybrid type quadrupole-TOF tandem mass spectrometer
[34].  However, even more sensitive and accurate are the
ion trap mass analyzers (e.g., Fourier transform ion
cyclotron resonance mass spectrometer), which have the
ability to store ions and then selectively eject them from
the ion trap unlike the quadrupole mass analyzer in which
ions are discarded before analysis begins [35,36].  These
mass analyzers also have the unique ability to perform
multiple stages of mass spectrometry.
Quantification of Proteins
In 2-DE, in order to compare the expression of proteins
between different samples, gels are often scanned and
subjected to image analysis.  The evaluation and
comparison of the complex 2-DE profiles with the eye is
impossible.  For a proper evaluation, it is important to
acquire the image as a grey-scale TIFF file with adequate
resolution.  Gels with visible spots have to be scanned in
Table 1: Common databases for peptide search in the internet.
Site name URL Information




FindMod www.expasy.ch/tools/findmod Post-translational modification
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transmission mode while blot membranes are scanned in
reflectance mode.  Dedicated scanners are required to
scan proteins that are labeled with fluorescent dyes or
radioisotopes.
Quantification of individual protein spots can be
performed by using computerized image analysis.  Many
image analysis softwares are currently available.
PDQuest, ImageMaster, MELANIE and Progenesis are
among the common softwares widely used by researchers.
All of these softwares have the capability to quantify the
expression of peptide spots in the form of volume (i.e.,
optical density x area in square mm of the region)
subsequent to a background intensity correction.  Some
are sophisticated enough to match gels, correct gel
distortion and perform automated quantification of
annotated proteins.  Also currently available is software
solely meant for the quantitative image analysis of 2-DE
gels that simultaneously separate two distinct protein
samples that are labeled with different spectrally
resolvable fluorescent dyes [37].  Because samples are
distinctively labeled, differential expression of proteins
can be detected directly using this method.  Besides
computerized image analysis, quantification can also be
performed using mass spectrometers [38].  However, this
requires the creation of internal standards, which must be
chemically similar to the molecule that is to be measured
by mass spectrometry, for each molecule to be measured.
Challenges for Proteomics
The last decade has seen an explosion of data derived
from proteomics research as well as tremendous
improvements in the technology of proteomics.  Despite
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